An evaluation of B-type Natriuretic Peptide in Addition to Myoglobin, Creatine Kinase-MB, and Troponin I on the Emergency Department Patients with Acute Myocardial Infarction
Keywords:
B-type natriuretic peptide, myocardial infarction, diagnosisAbstract
Objective: To assess the accuracy of B-type natriuretic peptide (BNP) in addition to myoglobin, creatine kinase-MB (CKMB),
and troponin I to diagnose patients with non ST-segment elevation myocardial infarction (NSTEMI) at the emergency
department.
Methods: During January to July 2007, a total of 100 patients with suspected acute myocardial infarction at the emergency
department were included. 50 were classified as NSTEMI and 50 as non-NSTEMI according to the final hospital diagnosis.
Blood samples for investigation of myoglobin, CK-MB, troponin I, and BNP analysis were collected in EDTA tubes
concomitantly with routine blood specimens from the emergency department and measured by Biosite Triage Cardioprofiler
Panel (Biosite Inc., San Diego, CA)
Results: The diagnostic sensitivity of Myoglobin and BNP (cut-off value of 100 pg/mL) for acute myocardial infarction
(AMI) was significantly higher than CK-MB and troponin-I at the emergency department (76 and 82 vs. 36 and 24%,
respectively, P< 0.001). BNP in addition to myoglobin, CK-MB, and troponin I improved the diagnostic sensitivity from
86% to 100%. The optimum cut-off point levels for myoglobin, CK-MB, troponin-I, and BNP were 150 ng/mL, 3.8 ng/mL,
0.15 ng/mL and 147 pg/mL respectively. Using the optimal cut-off point, the sensitivity was 96% and specificity was 46%
in diagnosis for myocardial infarction.
Conclusion: Multiple cardiac markers by use of quantitative point-of-care testing for myoglobin, CK-MB, troponin-I and
BNP are useful for ruling out patients presenting to the emergency department with suspected NSTEMI.
Downloads
Published
How to Cite
Issue
Section
License
Users are free to share, copy, and redistribute all articles published in the Siriraj Medical Journal (SMJ) in any medium or format as long as you follow the following terms:
- Attribution — You must give appropriate credit, provide a link to the material, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the publisher endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.